| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.02 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |